Open-Label Expanded Access for Ebola-Infected Patients to Receive Human MAb Ansuvimab As Therapeutic or for HR PEP

Conditions

• Ebola Virus Disease

Interventions

• DRUG: Ansuvimab

Sponsor

Ridgeback Biotherapeutics, LP